JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Intuitive Surgical Inc

Suletud

SektorTervishoid

471.65 0.36

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

468.33

Max

475.46

Põhinäitajad

By Trading Economics

Sissetulek

-45M

658M

Müük

187M

2.4B

P/E

Sektori keskmine

67.603

34.393

Aktsiakasum

1.81

Kasumimarginaal

26.984

Töötajad

15,638

EBITDA

268M

987M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+28.25% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

16. okt 2025

Turustatistika

By TradingEconomics

Turukapital

-12B

173B

Eelmine avamishind

471.29

Eelmine sulgemishind

471.65

Uudiste sentiment

By Acuity

10%

90%

5 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. juuli 2025, 21:13 UTC

Tulu

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22. apr 2025, 20:55 UTC

Tulu

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23. jaan 2025, 21:41 UTC

Tulu

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. jaan 2025, 18:37 UTC

Omandamised, ülevõtmised, äriostud

Intuitive to Establish Direct Presence in Europe With Acquisition

22. juuli 2025, 20:14 UTC

Tulu

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22. juuli 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22. juuli 2025, 20:13 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Net $658.4M >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Rev $2.44B >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q EPS $1.81 >ISRG

22. apr 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Net $698.4M >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. jaan 2025, 21:17 UTC

Tulu

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. jaan 2025, 18:18 UTC

Tulu

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. jaan 2025, 13:11 UTC

Peamised uudised

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. jaan 2025, 09:51 UTC

Kuumad aktsiad

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. jaan 2025, 21:10 UTC

Tulu

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Net $685.7M >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q EPS $1.88 >ISRG

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

28.25% tõus

12 kuu keskmine prognoos

Keskmine 602.89 USD  28.25%

Kõrge 685 USD

Madal 440 USD

Põhineb 22 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

22 ratings

17

Osta

4

Hoia

1

Müü

Tehniline skoor

By Trading Central

514.59 / 539.05Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

5 / 374 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.